Therefore, ATF6β could promote the production of adipocytokines, and then the adipocytokines lead to insulin resistance via blocking PI3K-AKT-mediated inhibition of lipolysis attenuating the capacity of glucose utilization (45). The gene discussed is ATF6B; the disease is Insulin resistance.